Literature DB >> 24560667

PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.

Shuang Liu1, Li Lai2, Qiuhong Zuo2, Fujun Dai2, Lin Wu2, Yan Wang2, Qingxia Zhou2, Jian Liu3, Jiang Liu4, Lei Li2, Qingxiang Lin2, Chad J Creighton5, Myra Grace Costello3, Shixia Huang3, Caifeng Jia2, Lujian Liao2, Honglin Luo6, Junjiang Fu7, Mingyao Liu2, Zhengfang Yi8, Jianru Xiao9, Xiaotao Li10.   

Abstract

The REGγ-proteasome serves as a short-cut for the destruction of certain intact mammalian proteins in the absence of ubiquitin- and ATP. The biological roles of the proteasome activator REGγ are not completely understood. Here we demonstrate that REGγ controls degradation of protein kinase A catalytic subunit-α (PKAca) both in primary human umbilical vein endothelial cells (HUVECs) and mouse embryonic fibroblast cells (MEFs). Accumulation of PKAca in REGγ-deficient HUVECs or MEFs results in phosphorylation and nuclear exclusion of the transcription factor FoxO1, indicating that REGγ is involved in preserving FoxO1 transcriptional activity. Consequently, VEGF-induced expression of the FoxO1 responsive genes, VCAM-1 and E-Selectin, was tightly controlled by REGγ in a PKA dependent manner. Functionally, REGγ is crucial for the migration of HUVECs. REGγ(-/-) mice display compromised VEGF-instigated neovascularization in cornea and aortic ring models. Implanted matrigel plugs containing VEGF in REGγ(-/-) mice induced fewer capillaries than in REGγ(+/+) littermates. Taken together, our study identifies REGγ as a novel angiogenic factor that plays an important role in VEGF-induced expression of VCAM-1 and E-Selectin by antagonizing PKA signaling. Identification of the REGγ-PKA-FoxO1 pathway in endothelial cells (ECs) provides another potential target for therapeutic intervention in vascular diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; E-Selectin; FoxO1; PKAca; REGγ; VCAM-1

Mesh:

Substances:

Year:  2014        PMID: 24560667      PMCID: PMC4237316          DOI: 10.1016/j.yjmcc.2014.02.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  59 in total

Review 1.  FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.

Authors:  Domenico Accili; Karen C Arden
Journal:  Cell       Date:  2004-05-14       Impact factor: 41.582

2.  Immune defects in 28-kDa proteasome activator gamma-deficient mice.

Authors:  Lance F Barton; Herbert A Runnels; Todd D Schell; Yunjung Cho; Reta Gibbons; Satvir S Tevethia; George S Deepe; John J Monaco
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

3.  Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit.

Authors:  C H Clegg; L A Correll; G G Cadd; G S McKnight
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

4.  Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway.

Authors:  P Ghersa; R Hooft van Huijsduijnen; J Whelan; Y Cambet; R Pescini; J F DeLamarter
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

5.  Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.

Authors:  D Shweiki; A Itin; G Neufeld; H Gitay-Goren; E Keshet
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Soluble E-selectin in arthritis.

Authors:  A E Koch; W Turkiewicz; L A Harlow; R M Pope
Journal:  Clin Immunol Immunopathol       Date:  1993-10

7.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Authors:  N Weidner; J Folkman; F Pozza; P Bevilacqua; E N Allred; D H Moore; S Meli; G Gasparini
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

Review 8.  The role of angiogenesis in tumor growth.

Authors:  J Folkman
Journal:  Semin Cancer Biol       Date:  1992-04       Impact factor: 15.707

9.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

10.  Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice.

Authors:  Tatsuo Furuyama; Kazuko Kitayama; Yuri Shimoda; Minetaro Ogawa; Kiyoaki Sone; Kiyomi Yoshida-Araki; Hiroshi Hisatsune; Shin-ichi Nishikawa; Keiko Nakayama; Keiichi Nakayama; Kyoji Ikeda; Noboru Motoyama; Nozomu Mori
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

View more
  13 in total

1.  Proteasome-Dependent Regulation of Distinct Metabolic States During Long-Term Culture of Human iPSC-Derived Cardiomyocytes.

Authors:  Antje Ebert; Amit U Joshi; Sandra Andorf; Yuanyuan Dai; Shrivatsan Sampathkumar; Haodong Chen; Yingxin Li; Priyanka Garg; Karl Toischer; Gerd Hasenfuss; Daria Mochly-Rosen; Joseph C Wu
Journal:  Circ Res       Date:  2019-05-20       Impact factor: 17.367

2.  Expression of REGγ in atherosclerotic plaques and promotes endothelial cells apoptosis via the cyclophilin A pathway indicates functional implications in atherogenesis.

Authors:  Yifan Xie; Xiaotao Li; Junbo Ge
Journal:  Cell Cycle       Date:  2019-07-07       Impact factor: 4.534

3.  Upregulation of GSK3β Contributes to Brain Disorders in Elderly REGγ-knockout Mice.

Authors:  Yiqing Lv; Bo Meng; Hao Dong; Tiantian Jing; Nan Wu; Yingying Yang; Lan Huang; Robb E Moses; Bert W O'Malley; Bing Mei; Xiaotao Li
Journal:  Neuropsychopharmacology       Date:  2015-09-15       Impact factor: 7.853

4.  Regulation of c-Myc protein stability by proteasome activator REGγ.

Authors:  S Li; C Jiang; J Pan; X Wang; J Jin; L Zhao; W Pan; G Liao; X Cai; X Li; J Xiao; J Jiang; P Wang
Journal:  Cell Death Differ       Date:  2014-11-21       Impact factor: 15.828

5.  Suicide gene therapy-mediated purine nucleoside phosphorylase/fludarabine system for in vitro breast cancer model with emphasis on evaluation of vascular endothelial growth factor promoter efficacy.

Authors:  Akbar Abbaspour; Abdolreza Esmaeilzadeh; Ali Sharafi
Journal:  3 Biotech       Date:  2021-02-24       Impact factor: 2.406

6.  Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.

Authors:  Jing Li; Xiaodong Feng; Chongkun Sun; Xin Zeng; Liang Xie; Hao Xu; Taiwen Li; Ruinan Wang; Xiaoping Xu; Xikun Zhou; Min Zhou; Yu Zhou; Hongxia Dan; Zhiyong Wang; Ning Ji; Peng Deng; Ga Liao; Ning Geng; Yun Wang; Dunfang Zhang; Yunfeng Lin; Ling Ye; Xinhua Liang; Longjiang Li; Gang Luo; Lu Jiang; Zhi Wang; Qianming Chen
Journal:  EBioMedicine       Date:  2015-07-10       Impact factor: 8.143

7.  The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis.

Authors:  Jinjin Xu; Lei Zhou; Lei Ji; Fengyuan Chen; Karen Fortmann; Kun Zhang; Qingwu Liu; Ke Li; Weicang Wang; Hao Wang; Wei Xie; Qingwei Wang; Jiang Liu; Biao Zheng; Pei Zhang; Shixia Huang; Tieliu Shi; Biaohong Zhang; Yongyan Dang; Jiwu Chen; Bert W O'Malley; Robb E Moses; Ping Wang; Lei Li; Jianru Xiao; Alexander Hoffmann; Xiaotao Li
Journal:  Nat Commun       Date:  2016-02-22       Impact factor: 14.919

8.  Proteasome activator REGγ promotes inflammation in Leydig cells via IkBε signaling.

Authors:  Tiancheng Xie; Hui Chen; Shihui Shen; Tingmei Huang; Bisheng Huang; Guanghui Hu; Lei Li; Yunfei Xu
Journal:  Int J Mol Med       Date:  2019-02-27       Impact factor: 4.101

9.  The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα-SOD2 pathway.

Authors:  Yifan Xie; Yang Gao; Rifeng Gao; Wenlong Yang; Zheng Dong; Robb E Moses; Aijun Sun; Xiaotao Li; Junbo Ge
Journal:  Cell Death Differ       Date:  2020-05-18       Impact factor: 15.828

Review 10.  PA28γ, an Accomplice to Malignant Cancer.

Authors:  Kexin Lei; Hetian Bai; Silu Sun; Chuan Xin; Jing Li; Qianming Chen
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.